Want to join the conversation?
As result of divestiture of $AGN's Global Generics business to $TEVA on July 27, the financial results of $AGN's Global Generics business are being reported as discontinued operations for 3Q15. These portions of results will continue to be reported as discontinued operations until close of transaction, expected to occur in 1Q16.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)